Lispro and regular insulin in pregnancy a comparison. 60th American Diabetes Association Meeting 2000.Bhattacharyya A, Borown S, Hughes SM, Vioce PA. Lispro and regular insulin in pregnancy: A comparison. (Abstract) Diabetes 2000; 49 (Suppl. 1): A441....
The incidences of congenital anomalies with regular insulin were 7.9% and 15.8% in gestational and pre-gestational diabetes, respectively; the figures for insulin lispro were 6.6% (p=0.79) and 3.8% ( p=0.16), respectively. Nineteen of the 22 surveyed patients completed the questionnaire. ...
and regular insulin were simulated with dosages that ranged from 0 to 6 units; the resulting GV was analyzed after each insulin injection. The numerical model used consists of a set of non-linear differential equations with two time delays and five adjustable parameters. The results show that...
, can be given 15 minutes before a meal or with a meal, peaks in 30 to 90 minutes,keeps working for less than five hours (usually two to four hours), should generally be used in regimens with intermediate or long-acting insulin and is more convenient and safer than regular insulin. ...
摘要: Aims: To compare the end-organ metabolic effects of insulin glulisine (glulisine), insulin lispro (lispro) and regular human insulin (RHI) in patients with type 1 diabetes mellitus.关键词:euglycaemic glucose clamp glulisine lispro ...
We performed a meta-analysis to compare insulin lispro and human regular insulin across a range of outcomes common in modern diabetes management to establish a basis for subsequent economic evaluation. We included all identifiable head-to-head randomized controlled trials, pooling dichotomous and ...
This study compared glycemic control achieved with insulin lispro or buffered regular human insulin in patients with Type 1 diabetes treated with continuous subcutaneous insulin infusion (CSII) using an external insulin pump. In this 24-week multicenter, randomized, two-way crossover, open-label tria...
Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes... A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patien... ...
;long-acting —insulina de acción prolongada;NPH —insulina NPH;pre-mixed —insulina premezclada;rapid-acting —insulina de acción rápida;rapid-acting — analogueanálogo de insulina de acción rápida;recombinant —insulina recombinante;regular —insulina regular;to take —inyectarse insulina...
OBJECTIVE To compare the safety and efficacy of insulin aspart (IAsp), buffered regular insulin (BR), and insulin lispro administered by continuous subcutaneous insulin infusion (CSII) in patients with type 1 diabetes.RESEARCH DESIGN AND METHODS After completing a 4-week run-in period with BR, ...